drugset
drugset / Trial / NCT01668537

A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects

NCT01668537 ↗

Phase 2 Completed 651 enrolled Bavarian Nordic
RandomizedParallel-groupQuadruple-blindPrevention

Summary

A randomized, double-blind, multicenter Phase II trial to compare the immunogenicity and safety of a liquid-frozen and a freeze-dried formulation of IMVAMUNE (MVA-BN®) smallpox vaccine in vaccinia-naïve healthy subjects

Timeline

Start
2013-03
Primary completion
2014-01
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject IMVAMUNE Vaccine 1e+08 unknown Subcutaneous

Indications

smallpox